Retrospective study to estimate the prevalence of HER2-low breast cancer (BC) and describe its clinicopathological characteristics
Authors
Viale, G.Niikura, N.
Tokunaga, E.
Aleynikova, O.
Hayashi, N.
Sohn, J.
O'Brien, Ciara
Higgins, G.
Della, V.
James, G. D.
Moh, A.
Scotto, N.
Affiliation
European Institute of Oncology, University of Milan, Milan, ItalyIssue Date
2022
Metadata
Show full item recordCitation
Viale G, Niikura N, Tokunaga E, Aleynikova O, Hayashi N, Sohn J, et al. Retrospective study to estimate the prevalence of HER2-low breast cancer (BC) and describe its clinicopathological characteristics. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680300260.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2022.40.16_suppl.1087Additional Links
https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.1087Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.2022.40.16_suppl.1087